Cargando…

Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy

At present, language therapy is the only available treatment for childhood aphasia (CA). Studying new interventions to augment and hasten the benefits provided by language therapy in children is strongly needed. CA frequently emerges as a consequence of traumatic brain injury and, as in the case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Dávila, Guadalupe, Moyano, María Pilar, Edelkraut, Lisa, Moreno-Campos, Lorena, Berthier, Marcelo L., Torres-Prioris, María José, López-Barroso, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411310/
https://www.ncbi.nlm.nih.gov/pubmed/32848757
http://dx.doi.org/10.3389/fphar.2020.01144
_version_ 1783568350375313408
author Dávila, Guadalupe
Moyano, María Pilar
Edelkraut, Lisa
Moreno-Campos, Lorena
Berthier, Marcelo L.
Torres-Prioris, María José
López-Barroso, Diana
author_facet Dávila, Guadalupe
Moyano, María Pilar
Edelkraut, Lisa
Moreno-Campos, Lorena
Berthier, Marcelo L.
Torres-Prioris, María José
López-Barroso, Diana
author_sort Dávila, Guadalupe
collection PubMed
description At present, language therapy is the only available treatment for childhood aphasia (CA). Studying new interventions to augment and hasten the benefits provided by language therapy in children is strongly needed. CA frequently emerges as a consequence of traumatic brain injury and, as in the case of adults, it may be associated with dysfunctional activity of neurotransmitter systems. The use of cognitive-enhancing drugs, alone or combined with aphasia therapy, promotes improvement of language deficits in aphasic adults. In this study we report the case of a 9-year-old right-handed girl, subject P, who had chronic anomic aphasia associated with traumatic lesions in the left temporal-parietal cortex. We performed a single-subject, open-label study encompassing administration of the cholinergic agent donepezil (DP) alone during 12 weeks, followed by a combination of DP and intensive naming therapy (INT) for 2 weeks and thereafter by a continued treatment of DP alone during 12 weeks, a 4-week washout period, and another 2 weeks of INT. Four comprehensive language and neuropsychological evaluations were performed at different timepoints along the study, and multiple naming evaluations were performed after each INT in order to assess performance in treated and untreated words. Structural magnetic resonance imaging (MRI) was performed at baseline. MRI revealed two focal lesions in the left hemisphere, one large involving the posterior inferior and middle temporal gyri and another comprising the angular gyrus. Overall, baseline evaluation disclosed marked impairment in naming with mild-to-moderate compromise of spontaneous speech, repetition, and auditory comprehension. Executive and attention functions were also affected, but memory, visuoconstructive, and visuoperceptive functions were preserved. Treatment with DP alone significantly improved spontaneous speech, auditory comprehension, repetition, and picture naming, in addition to processing speed, selective, and sustained attention. Combined DP-INT further improved naming. After washout of both interventions, most of these beneficial changes remained. Importantly, DP produced no side effects and subject P attained the necessary level of language competence to return to regular schooling. In conclusion, the use of DP alone and in combination with INT improved language function and related cognitive posttraumatic deficits in a child with acquired aphasia. Further studies in larger samples are warranted.
format Online
Article
Text
id pubmed-7411310
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74113102020-08-25 Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy Dávila, Guadalupe Moyano, María Pilar Edelkraut, Lisa Moreno-Campos, Lorena Berthier, Marcelo L. Torres-Prioris, María José López-Barroso, Diana Front Pharmacol Pharmacology At present, language therapy is the only available treatment for childhood aphasia (CA). Studying new interventions to augment and hasten the benefits provided by language therapy in children is strongly needed. CA frequently emerges as a consequence of traumatic brain injury and, as in the case of adults, it may be associated with dysfunctional activity of neurotransmitter systems. The use of cognitive-enhancing drugs, alone or combined with aphasia therapy, promotes improvement of language deficits in aphasic adults. In this study we report the case of a 9-year-old right-handed girl, subject P, who had chronic anomic aphasia associated with traumatic lesions in the left temporal-parietal cortex. We performed a single-subject, open-label study encompassing administration of the cholinergic agent donepezil (DP) alone during 12 weeks, followed by a combination of DP and intensive naming therapy (INT) for 2 weeks and thereafter by a continued treatment of DP alone during 12 weeks, a 4-week washout period, and another 2 weeks of INT. Four comprehensive language and neuropsychological evaluations were performed at different timepoints along the study, and multiple naming evaluations were performed after each INT in order to assess performance in treated and untreated words. Structural magnetic resonance imaging (MRI) was performed at baseline. MRI revealed two focal lesions in the left hemisphere, one large involving the posterior inferior and middle temporal gyri and another comprising the angular gyrus. Overall, baseline evaluation disclosed marked impairment in naming with mild-to-moderate compromise of spontaneous speech, repetition, and auditory comprehension. Executive and attention functions were also affected, but memory, visuoconstructive, and visuoperceptive functions were preserved. Treatment with DP alone significantly improved spontaneous speech, auditory comprehension, repetition, and picture naming, in addition to processing speed, selective, and sustained attention. Combined DP-INT further improved naming. After washout of both interventions, most of these beneficial changes remained. Importantly, DP produced no side effects and subject P attained the necessary level of language competence to return to regular schooling. In conclusion, the use of DP alone and in combination with INT improved language function and related cognitive posttraumatic deficits in a child with acquired aphasia. Further studies in larger samples are warranted. Frontiers Media S.A. 2020-07-31 /pmc/articles/PMC7411310/ /pubmed/32848757 http://dx.doi.org/10.3389/fphar.2020.01144 Text en Copyright © 2020 Dávila, Moyano, Edelkraut, Moreno-Campos, Berthier, Torres-Prioris and López-Barroso http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Dávila, Guadalupe
Moyano, María Pilar
Edelkraut, Lisa
Moreno-Campos, Lorena
Berthier, Marcelo L.
Torres-Prioris, María José
López-Barroso, Diana
Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy
title Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy
title_full Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy
title_fullStr Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy
title_full_unstemmed Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy
title_short Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy
title_sort pharmacotherapy of traumatic childhood aphasia: beneficial effects of donepezil alone and combined with intensive naming therapy
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411310/
https://www.ncbi.nlm.nih.gov/pubmed/32848757
http://dx.doi.org/10.3389/fphar.2020.01144
work_keys_str_mv AT davilaguadalupe pharmacotherapyoftraumaticchildhoodaphasiabeneficialeffectsofdonepezilaloneandcombinedwithintensivenamingtherapy
AT moyanomariapilar pharmacotherapyoftraumaticchildhoodaphasiabeneficialeffectsofdonepezilaloneandcombinedwithintensivenamingtherapy
AT edelkrautlisa pharmacotherapyoftraumaticchildhoodaphasiabeneficialeffectsofdonepezilaloneandcombinedwithintensivenamingtherapy
AT morenocamposlorena pharmacotherapyoftraumaticchildhoodaphasiabeneficialeffectsofdonepezilaloneandcombinedwithintensivenamingtherapy
AT berthiermarcelol pharmacotherapyoftraumaticchildhoodaphasiabeneficialeffectsofdonepezilaloneandcombinedwithintensivenamingtherapy
AT torrespriorismariajose pharmacotherapyoftraumaticchildhoodaphasiabeneficialeffectsofdonepezilaloneandcombinedwithintensivenamingtherapy
AT lopezbarrosodiana pharmacotherapyoftraumaticchildhoodaphasiabeneficialeffectsofdonepezilaloneandcombinedwithintensivenamingtherapy